Literature DB >> 24327209

Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target?

Elizabeth Yakaboski1, Alexander Jares1, Yupo Ma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24327209      PMCID： PMC4290879          DOI： 10.1002/hep.26956

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  18 in total

1.  SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.

Authors:  Daisuke Kobayashi; Kageaki Kuribayshi; Maki Tanaka; Naoki Watanabe
Journal:  Int J Oncol       Date:  2011-01-27       Impact factor: 5.650

2.  Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts.

Authors:  Noriko Tsubooka; Tomoko Ichisaka; Keisuke Okita; Kazutoshi Takahashi; Masato Nakagawa; Shinya Yamanaka
Journal:  Genes Cells       Date:  2009-05-19       Impact factor: 1.891

3.  Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.

Authors:  Pingping Hou; Yanqin Li; Xu Zhang; Chun Liu; Jingyang Guan; Honggang Li; Ting Zhao; Junqing Ye; Weifeng Yang; Kang Liu; Jian Ge; Jun Xu; Qiang Zhang; Yang Zhao; Hongkui Deng
Journal:  Science       Date:  2013-07-18       Impact factor: 47.728

4.  Overexpression of SALL4 in lung cancer and its importance in cell proliferation.

Authors:  Daisuke Kobayashi; Kageaki Kuribayashi; Maki Tanaka; Naoki Watanabe
Journal:  Oncol Rep       Date:  2011-07-01       Impact factor: 3.906

5.  Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

Authors:  Jens U Marquardt; Chiara Raggi; Jesper B Andersen; Daekwan Seo; Itzhak Avital; David Geller; Yun-Han Lee; Mitsuteru Kitade; Agnes Holczbauer; Matthew C Gillen; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

Review 6.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

7.  Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.

Authors:  Wei Cui; Nikki R Kong; Yupo Ma; Hesham M Amin; Raymond Lai; Li Chai
Journal:  Mod Pathol       Date:  2006-09-22       Impact factor: 7.842

8.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.

Authors:  Jianchang Yang; Jerell R Aguila; Zaida Alipio; Raymond Lai; Louis M Fink; Yupo Ma
Journal:  J Hematol Oncol       Date:  2011-09-23       Impact factor: 17.388

10.  The molecular pathogenesis and clinical implications of hepatocellular carcinoma.

Authors:  Makoto Meguro; Toru Mizuguchi; Masaki Kawamoto; Koichi Hirata
Journal:  Int J Hepatol       Date:  2011-12-04
View more
  10 in total

1.  Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study.

Authors:  Song Su; Kai He; Jing Li; Jiali Wu; Mengyu Zhang; Chunhong Feng; Xianming Xia; Bo Li
Journal:  Tumour Biol       Date:  2015-04-19

2.  Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.

Authors:  Xia Gao; Wenxuan Liu; Xiaolin Zhang; Longmei Tang; Liqin Wang; Lina Yan; Haitao Yang; Tao Li; Lei Yang; Ning Ma; Dianwu Liu
Journal:  Tumour Biol       Date:  2016-05-21

3.  Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.

Authors:  Liyuan Li; Maoxiang Qian; I-Hsuan Chen; David Finkelstein; Arzu Onar-Thomas; Melissa Johnson; Christopher Calabrese; Armita Bahrami; Dolores H López-Terrada; Jun J Yang; W Andy Tao; Liqin Zhu
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

4.  Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.

Authors:  K Sideras; S J Bots; K Biermann; D Sprengers; W G Polak; J N M IJzermans; R A de Man; Q Pan; S Sleijfer; M J Bruno; J Kwekkeboom
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

Review 5.  The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.

Authors:  Yanhong Xiao; Mei Lin; Xingmao Jiang; Jun Ye; Ting Guo; Yujuan Shi; Xuefeng Bian
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-27       Impact factor: 2.916

Review 6.  SALL4: An Intriguing Therapeutic Target in Cancer Treatment.

Authors:  Shiva Moein; Daniel G Tenen; Giovanni Amabile; Li Chai
Journal:  Cells       Date:  2022-08-20       Impact factor: 7.666

7.  Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

Authors:  Laura Broutier; Gianmarco Mastrogiovanni; Monique Ma Verstegen; Hayley E Francies; Lena Morrill Gavarró; Charles R Bradshaw; George E Allen; Robert Arnes-Benito; Olga Sidorova; Marcia P Gaspersz; Nikitas Georgakopoulos; Bon-Kyoung Koo; Sabine Dietmann; Susan E Davies; Raaj K Praseedom; Ruby Lieshout; Jan N M IJzermans; Stephen J Wigmore; Kourosh Saeb-Parsy; Mathew J Garnett; Luc Jw van der Laan; Meritxell Huch
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

8.  Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer.

Authors:  Wenjing Du; Lan Ni; Baojun Liu; Ying Wei; Yubao Lv; Sujing Qiang; Jingcheng Dong; Xijun Liu
Journal:  Oncogenesis       Date:  2018-04-25       Impact factor: 7.485

9.  Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis.

Authors:  Bixing Zhao; Yingchao Wang; Xionghong Tan; Kun Ke; Xiaoyuan Zheng; Fei Wang; Shubing Lan; Naishun Liao; Zhixiong Cai; Yingjun Shi; Youshi Zheng; Yongping Lai; Lili Wang; Qin Li; Jingfeng Liu; Aimin Huang; Xiaolong Liu
Journal:  Mol Ther Oncolytics       Date:  2019-09-10       Impact factor: 7.200

10.  Expression and clinical value of SALL4 in renal cell carcinomas.

Authors:  Jianping Che; Pengfei Wu; Guangchun Wang; Xudong Yao; Junhua Zheng; Changcheng Guo
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.